The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure

Brain Research

Volumn 1069, Issue 1, 2006, Pages 120-126

  Jin, Chunyu ^a,c   Araki, Hiroaki ^b   Kawasaki, Yoichi ^a   Nagata, Mari ^a   Suemaru, Katsuya ^b   Shibata, Kazuhiko ^a   Hamamura, Takashi ^a   Kawasaki, Hiromu ^c   Gomita, Yutaka ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Acute dependence; Amygdala; Glutamate; Morphine; Riluzole; Withdrawal aversion

Indexed keywords

GLUTAMIC ACID; MORPHINE; NALOXONE; PROTEIN C FOS; RILUZOLE;

ADAPTATION; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG WITHDRAWAL; MALE; MORPHINE ADDICTION; MOTIVATION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CELL COUNT; CONDITIONING, OPERANT; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RILUZOLE;

ANIMALIA;

EID: 31344456489     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.11.058     Document Type: Article

References (38)

1. G.K. Aghajanian, J.H. Kogan, and B. Moghaddam Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study Brain Res. 636 1994 126 130
2. H. Araki, K. Kawakami, C. Jin, K. Suemaru, Y. Kitamura, M. Nagata, K. Futagami, K. Shibata, H. Kawasaki, and Y. Gomita Nicotine attenuates place aversion induced by naloxone in single-dose morphine treated rats Psychopharmacology 171 2004 398 404
3. E.A. Blokhina, I.A. Sukhotina, and A.Y. Bespalov Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists Eur. J. Pharmacol. 406 2000 227 232
4. S.L. Cappendijk, R. de Vries, and M.R. Dzoljic Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice Eur. Neuropsychopharmacol. 3 1993 111 116
5. W. Danysz, W. Zajaczkowski, and C.G. Parsons Modulation of learning processes by ionotropic glutamate receptor ligands Behav. Pharmacol. 6 1995 455 474
6. M. Davis, D. Rainnie, and M. Cassell Neurotransmission in the rat amygdala related to fear and anxiety Trends Neurosci. 17 1994 208 214
7. A. Doble The pharmacology and mechanism of action of riluzole Neurology 47 1996 S233 S241
8. F. Frenois, M. Cador, S. Caille, L. Stinus, and C. Le Moine Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal Eur. J. Neurosci. 16 2002 1377 1389
9. V.F. Gellert, and S.B. Sparber A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats J. Pharmacol. Exp. Ther. 201 1977 44 54
10. K.N. Gracy, L.A. Dankiewicz, and G.F. Koob Opiate withdrawal-induced Fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion Neuropsychopharmacology 24 2001 152 160
11. S.J. Heishman, M.L. Stitzer, G.E. Bigelow, and I.A. Liebson Acute opioid physical dependence in humans: effect of naloxone at 6 and 24 hours postmorphine Pharmacol. Biochem. Behav. 36 1990 393 399
12. G.A. Higgins, P. Nguyen, and E.M. Sellers The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal Life Sci. 50 1992 PL167 PL172
13. C. Jin, H. Araki, M. Nagata, K. Suemaru, K. Shibata, H. Kawasaki, T. Hamamura, and Y. Gomita Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure Psychopharmacology 175 2004 428 435
14. C. Jin, H. Araki, M. Nagata, R. Shimosaka, K. Shibata, K. Suemaru, H. Kawasaki, and Y. Gomita Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence Behav. Brain Res. 161 2005 107 112
15. H.L. June, M.L. Stitzer, and E. Cone Acute physical dependence: time course and relation to human plasma morphine concentrations Clin. Pharmacol. Ther. 57 1995 270 280
16. Y. Kawasaki, C. Jin, K. Suemaru, H. Kawasaki, K. Shibata, T. Choshi, S. Hibino, Y. Gomita, and H. Araki Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats Br. J. Pharmacol. 145 2005 751 757
17. J.E. Kelsey, and S.R. Arnold Lesions of the dorsomedial amygdala, but not the nucleus accumbens, reduce the aversiveness of morphine withdrawal in rats Behav. Neurosci. 108 1994 1119 1127
18. G.F. Koob The role of the striatopallidal and extended amygdala systems in drug addiction Ann. N. Y. Acad. Sci. 877 1999 445 460
19. C. Malgouris, F. Bardot, M. Daniel, F. Pellis, J. Rataud, A. Uzan, J.C. Blanchard, and P.M. Laduron Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils J. Neurosci. 9 1989 3720 3727
20. R.V. McDonald, L.A. Parker, and S. Siegel Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine Pharmacol. Biochem. Behav. 58 1997 1003 1008
21. R.G. Morris, E. Anderson, G.S. Lynch, and M. Baudry Selective impairment of learning and blockade of long-term potentiation of an N-methyl-d-aspartate receptor antagonist, AP5 Nature 319 1986 774 776
22. L.A. Parker, J.A. Cyr, A.N. Santi, and P.D. Burton The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine evaluation by taste and place conditioning Pharmacol. Biochem. Behav. 72 2002 87 92
23. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates Third edition 1997 Academic Press San Diego
24. P. Popik, and W. Danysz Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-d-aspartate receptor antagonist, memantine J. Pharmacol. Exp. Ther. 280 1997 854 865
25. R. Przewlocki Opioid abuse and brain gene expression Eur. J. Pharmacol. 500 2004 331 349
26. K. Rasmussen, and J. Vandergriff The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal Neuropharmacology 44 2003 88 92
27. K. Rasmussen, R.W. Fuller, M.E. Stockton, K.W. Perry, R.M. Swinford, and P.L. Ornstein NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal Eur. J. Pharmacol. 197 1991 9 16
28. F. Rodriguez de Fonseca, and M. Navarro Role of the limbic system in dependence on drugs Ann. Med. 30 1998 397 405
29. M.J. Sepulveda, L. Hernandez, P. Rada, S. Tucci, and E. Contreras Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study Pharmacol. Biochem. Behav. 60 1998 255 262
30. J. Sepulveda, J.G. Astorga, and E. Contreras Riluzole decreases the abstinence syndrome and physical dependence in morphine-dependent mice Eur. J. Pharmacol. 379 1999 59 62
31. J.R. Taylor, L.J. Punch, and J.D. Elsworth A comparison of the effects of clonidine and CNQX infusion in to the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat Psychopharmacology 138 1998 133 142
32. S. Tokuyama, H. Wakabayashi, and I.K. Ho Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome Eur. J. Pharmacol. 295 1996 123 129
33. S. Tokuyama, H. Zhu, S. Oh, I.K. Ho, and T. Yamamoto Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids Neurochem. Int. 39 2001 103 109
34. T.M. Tzschentke, and W.J. Schmidt Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole Neurosci. Lett. 242 1998 114 116
35. T.M. Tzschentke, and W.J. Schmidt Glutamatergic mechanisms in addiction Mol. Psychiatry 8 2003 373 382
36. J. Vandergriff, and K. Rasmussen The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal Neuropharmacology 38 1999 217 222
37. T. Watanabe, T. Nakagawa, R. Yamamoto, A. Maeda, M. Minami, and M. Satoh Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats Jpn. J. Pharmacol. 88 2002 399 406
38. T. Zhang, Y. Feng, R.W. Rockhold, and I.K. Ho Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat Life Sci. 55 1994 PL25 PL31